ATE219247T1 - Methoden zur feststellung von alzheimerscher krankheit - Google Patents

Methoden zur feststellung von alzheimerscher krankheit

Info

Publication number
ATE219247T1
ATE219247T1 AT96944954T AT96944954T ATE219247T1 AT E219247 T1 ATE219247 T1 AT E219247T1 AT 96944954 T AT96944954 T AT 96944954T AT 96944954 T AT96944954 T AT 96944954T AT E219247 T1 ATE219247 T1 AT E219247T1
Authority
AT
Austria
Prior art keywords
disease
methods
alzheimer
detecting alzheimer
detection
Prior art date
Application number
AT96944954T
Other languages
English (en)
Inventor
Marguerite M B Kay
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Application granted granted Critical
Publication of ATE219247T1 publication Critical patent/ATE219247T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT96944954T 1996-01-19 1996-12-13 Methoden zur feststellung von alzheimerscher krankheit ATE219247T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1025096P 1996-01-19 1996-01-19
PCT/US1996/020465 WO1997026537A1 (en) 1996-01-19 1996-12-13 Methods for the detection of alzheimer's disease

Publications (1)

Publication Number Publication Date
ATE219247T1 true ATE219247T1 (de) 2002-06-15

Family

ID=21744819

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96944954T ATE219247T1 (de) 1996-01-19 1996-12-13 Methoden zur feststellung von alzheimerscher krankheit

Country Status (7)

Country Link
EP (1) EP0877939B1 (de)
JP (1) JP2000503391A (de)
AT (1) ATE219247T1 (de)
CA (1) CA2242343A1 (de)
DE (1) DE69621837T2 (de)
ES (1) ES2176523T3 (de)
WO (1) WO1997026537A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301730A (zh) * 1999-12-24 2001-07-04 上海博德基因开发有限公司 一种新的多肽——阴离子交换蛋白9和编码这种多肽的多核苷酸
CN1301720A (zh) * 1999-12-27 2001-07-04 上海博德基因开发有限公司 一种新的多肽——阴离子交换蛋白9和编码这种多肽的多核苷酸
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
HRP20140240T4 (hr) 2005-11-30 2017-02-24 Abbvie Inc. Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba
US8691224B2 (en) 2005-11-30 2014-04-08 Abbvie Inc. Anti-Aβ globulomer 5F7 antibodies
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
EP3533803B1 (de) 2010-08-14 2021-10-27 AbbVie Inc. Anti-amyloid-beta antikörper
US9588129B2 (en) 2013-03-15 2017-03-07 Amira Medical Technologies Inc. Methods for analyzing blood to detect diseases associated with abnormal protein aggregation

Also Published As

Publication number Publication date
EP0877939B1 (de) 2002-06-12
EP0877939A1 (de) 1998-11-18
ES2176523T3 (es) 2002-12-01
JP2000503391A (ja) 2000-03-21
CA2242343A1 (en) 1997-07-24
WO1997026537A1 (en) 1997-07-24
DE69621837T2 (de) 2002-11-28
DE69621837D1 (de) 2002-07-18

Similar Documents

Publication Publication Date Title
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DE69612017D1 (de) Emulsion zur robusten erfassung von gasen
DE69114869D1 (de) Verfahren zur Bestimmung des Profils von Reifen.
EP1116029A4 (de) Antikörper für apoptosemarker und anwendungsverfahren
AU698862B2 (en) A screening method for identifying ligands for target proteins
DE69621837D1 (de) Methoden zur feststellung von alzheimerscher krankheit
SE9604815D0 (sv) A metod of diagnosis
NO885013D0 (no) FremgangsmŸte for fremstilling av bionedbrytbare mikrokapsler av vannopplelige peptider og proteiner, samt mikroka psler oppnŸdd ved fremgangsmŸten.
DE69535901D1 (de) Proteinkinase npk-110
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
ATE342510T1 (de) Komplementierungsassay für den nachweis von protein-löslichkeit und -faltung
DE69021729D1 (de) Verfahren zur gewinnung von natürlich hergestelltem chymosin.
ATE291230T1 (de) Verwendung von methoden zur identifizierung von hydrophilen signal-oligopeptiden
DE69717001D1 (de) Verfahren zur Bestimmung des Endpunktes von enzymatischen Nachweisverfahren
NO986218L (no) FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100
DE69018840D1 (de) Verfahren und Vorrichtung zur Bestimmung des mittleren arteriellen Blutdruckes.
ATE292800T1 (de) Immunologische bestimmung des hydrophoben lungensurfaktantproteins sp-c
ATE294237T1 (de) S?ugetier thymokingene
DE59108478D1 (de) Funktioneller Test zur Bestimmung der Protein S-Aktivität
ATE347613T1 (de) Verfahren zur bestimmung von alkalischer phosphatase unter beseitigung von hämoglobin- störungen
ATE220678T1 (de) Verfahren zur gewinnung von hämin aus schlachtblut
WO2002009576A3 (en) Avian pneumovirus diagnostic system
DE59708783D1 (de) Diagnosehilfe sowie verfahren zum nachweis der trächtigkeit von wiederkäuern
DE69533200D1 (de) Verfahren zur prüfung von immunokompetenz

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee